170 related articles for article (PubMed ID: 34919342)
1. Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells.
Mammadli M; Harris R; Suo L; May A; Gentile T; Waickman AT; Bah A; August A; Nurmemmedov E; Karimi M
Clin Transl Med; 2021 Dec; 11(12):e625. PubMed ID: 34919342
[TBL] [Abstract][Full Text] [Related]
2. Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT.
Mammadli M; Huang W; Harris R; Sultana A; Cheng Y; Tong W; Pu J; Gentile T; Dsouza S; Yang Q; Bah A; August A; Karimi M
Front Immunol; 2020; 11():593863. PubMed ID: 33324410
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T Cells.
Kondo T; Ikegawa S; Fukumi T; Sumii Y; Sugiura H; Sando Y; Nakamura M; Meguri Y; Iwamoto M; Maeda Y; Matsuoka KI
Immunohorizons; 2021 Jun; 5(6):424-437. PubMed ID: 34112701
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
5. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
Front Immunol; 2018; 9():3104. PubMed ID: 30733722
[TBL] [Abstract][Full Text] [Related]
6. TCF-1 negatively regulates the suppressive ability of canonical and noncanonical Tregs.
Mammadli M; Suo L; Sen JM; Karimi M
J Leukoc Biol; 2023 May; 113(5):489-503. PubMed ID: 36806938
[TBL] [Abstract][Full Text] [Related]
7. A negative role for the interleukin-2-inducible T-cell kinase (ITK) in human Foxp3+ TREG differentiation.
Mamontov P; Eberwine RA; Perrigoue J; Das A; Friedman JR; Mora JR
PLoS One; 2019; 14(4):e0215963. PubMed ID: 31022269
[TBL] [Abstract][Full Text] [Related]
8. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
DeOca KB; Moorman CD; Garcia BL; Mannie MD
Front Immunol; 2020; 11():541619. PubMed ID: 33072087
[TBL] [Abstract][Full Text] [Related]
9. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells.
Gomez-Rodriguez J; Wohlfert EA; Handon R; Meylan F; Wu JZ; Anderson SM; Kirby MR; Belkaid Y; Schwartzberg PL
J Exp Med; 2014 Mar; 211(3):529-43. PubMed ID: 24534190
[TBL] [Abstract][Full Text] [Related]
10. Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17/Treg immune responses and reduction of oxidative stress.
Nadeem A; Al-Harbi NO; Ahmad SF; Al-Harbi MM; Alhamed AS; Alfardan AS; Assiri MA; Ibrahim KE; Albassam H
Int Immunopharmacol; 2020 Jun; 83():106369. PubMed ID: 32163900
[TBL] [Abstract][Full Text] [Related]
11. Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT.
Mammadli M; Huang W; Harris R; Xiong H; Weeks S; May A; Gentile T; Henty-Ridilla J; Waickman AT; August A; Bah A; Karimi M
iScience; 2021 Apr; 24(4):102286. PubMed ID: 33851101
[TBL] [Abstract][Full Text] [Related]
12. Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells.
Eken A; Cansever M; Somekh I; Mizoguchi Y; Zietara N; Okus FZ; Erdem S; Canatan H; Akyol S; Ozcan A; Karakukcu M; Hollizeck S; Rohlfs M; Unal E; Klein C; Patiroglu T
J Clin Immunol; 2019 May; 39(4):391-400. PubMed ID: 31025232
[TBL] [Abstract][Full Text] [Related]
13. Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.
Belle L; Agle K; Zhou V; Yin-Yuan C; Komorowski R; Eastwood D; Logan B; Sun J; Ghilardi N; Cua D; Williams CB; Gaignage M; Marillier R; van Snick J; Drobyski WR
Blood; 2016 Oct; 128(16):2068-2082. PubMed ID: 27488350
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial inhibition of Tec kinases BTK and ITK is beneficial in ameliorating murine sclerodermatous chronic graft versus host disease.
Palaniyandi S; Strattan E; Kumari R; Mysinger M; Hakim N; Kesler MV; Apatira M; Bittencourt F; Wang L; Jia Z; Gururaja TL; Hill RJ; Hildebrandt GC
Bone Marrow Transplant; 2023 Aug; 58(8):924-935. PubMed ID: 37160943
[TBL] [Abstract][Full Text] [Related]
16. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
[TBL] [Abstract][Full Text] [Related]
17. Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation.
Meguri Y; Asano T; Yoshioka T; Iwamoto M; Ikegawa S; Sugiura H; Kishi Y; Nakamura M; Sando Y; Kondo T; Sumii Y; Maeda Y; Matsuoka KI
Front Immunol; 2022; 13():891925. PubMed ID: 35983059
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice.
Horst AK; Wegscheid C; Schaefers C; Schiller B; Neumann K; Lunemann S; Langeneckert AE; Oldhafer KJ; Weiler-Normann C; Lang KS; Singer BB; Altfeld M; Diehl L; Tiegs G
Hepatology; 2018 Jul; 68(1):200-214. PubMed ID: 29377208
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.
Shin HJ; Baker J; Leveson-Gower DB; Smith AT; Sega EI; Negrin RS
Blood; 2011 Aug; 118(8):2342-50. PubMed ID: 21734238
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]